Literature DB >> 30341461

Long non-coding RNAs involved in cancer metabolic reprogramming.

Hui Liu1, Junyun Luo1, Siyu Luan1, Chongsheng He1, Zhaoyong Li2.   

Abstract

Metabolic reprogramming has now been accepted as a hallmark of cancer. Compared to normal cells, cancer cells exhibit different metabolic features, including increased glucose uptake, aerobic glycolysis, enhanced glutamine uptake and glutaminolysis, altered lipid metabolism, and so on. Cancer metabolic reprogramming, which supports excessive cell proliferation and growth, has been widely regulated by activation of oncogenes or loss of tumor suppressors. Here, we review that long non-coding RNAs (lncRNAs) can affect cancer metabolism by mutual regulation with oncogenes or tumor suppressors. Additionally, the interaction of lncRNAs with crucial transcription factors, metabolic enzymes or microRNAs can also effectively modulate the processes of cancer metabolism. LncRNAs-derived metabolism reprogramming allows cancer cells to maintain deregulated proliferation and withstand hostile microenvironment such as energy stress. Understanding the functions of lncRNAs in cancer metabolic reprogramming that contributes to carcinogenesis and cancer development may help to develop novel and effective strategies for cancer diagnosis, prognosis and treatment.

Entities:  

Keywords:  Cancer; Long non-coding RNA; Metabolism

Mesh:

Substances:

Year:  2018        PMID: 30341461     DOI: 10.1007/s00018-018-2946-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  83 in total

1.  p53 regulates mitochondrial respiration.

Authors:  Satoaki Matoba; Ju-Gyeong Kang; Willmar D Patino; Andrew Wragg; Manfred Boehm; Oksana Gavrilova; Paula J Hurley; Fred Bunz; Paul M Hwang
Journal:  Science       Date:  2006-05-25       Impact factor: 47.728

2.  TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

Authors:  Karim Bensaad; Atsushi Tsuruta; Mary A Selak; M Nieves Calvo Vidal; Katsunori Nakano; Ramon Bartrons; Eyal Gottlieb; Karen H Vousden
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

3.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.

Authors:  Katrin Panzitt; Marisa M O Tschernatsch; Christian Guelly; Tarek Moustafa; Martin Stradner; Heimo M Strohmaier; Charles R Buck; Helmut Denk; Renée Schroeder; Michael Trauner; Kurt Zatloukal
Journal:  Gastroenterology       Date:  2006-08-14       Impact factor: 22.682

4.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis.

Authors:  P J Greasley; C Bonnard; B Amati
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

5.  Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis.

Authors:  Feng Li; Yunyue Wang; Karen I Zeller; James J Potter; Diane R Wonsey; Kathryn A O'Donnell; Jung-Whan Kim; Jason T Yustein; Linda A Lee; Chi V Dang
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays.

Authors:  Jung-whan Kim; Karen I Zeller; Yunyue Wang; Anil G Jegga; Bruce J Aronow; Kathryn A O'Donnell; Chi V Dang
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.

Authors:  Gyorgy Petrovics; Wei Zhang; Mazen Makarem; Jesse P Street; Roger Connelly; Leon Sun; Isabell A Sesterhenn; Vasantha Srikantan; Judd W Moul; Shiv Srivastava
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

8.  The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.

Authors:  Fabiana Schwartzenberg-Bar-Yoseph; Michal Armoni; Eddy Karnieli
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.

Authors:  Joseph F Sanchez; Lynn F Sniderhan; Andrea L Williamson; Shongshan Fan; Shikha Chakraborty-Sett; Sanjay B Maggirwar
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.

Authors:  Reuben J Shaw; Monica Kosmatka; Nabeel Bardeesy; Rebecca L Hurley; Lee A Witters; Ronald A DePinho; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

View more
  27 in total

1.  Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p.

Authors:  Hanchen Li; Jiang Hong; Walimuni Sandaroo Mendis Abeysekara Wijayakulathilaka
Journal:  Cell Cycle       Date:  2019-10-07       Impact factor: 4.534

Review 2.  A review of literature: role of long noncoding RNA TPT1-AS1 in human diseases.

Authors:  Yi Li; Fulei Li; Zongzong Sun; Juan Li
Journal:  Clin Transl Oncol       Date:  2022-09-16       Impact factor: 3.340

3.  lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization.

Authors:  Kunming Zhao; Xingwen Wang; Dong Zhao; Qingyu Lin; Yi Zhang; Ying Hu
Journal:  Research (Wash D C)       Date:  2022-07-05

4.  Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.

Authors:  Zheng Li; Juan Zheng; Yang Feng; Yaming Li; Yiran Liang; Ying Liu; Xiaolong Wang; Qifeng Yang
Journal:  Cancer Med       Date:  2021-09-27       Impact factor: 4.452

Review 5.  The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.

Authors:  Yongcan Xu; Mantang Qiu; Minmin Shen; Shunli Dong; Guochao Ye; Xuefei Shi; Ming Sun
Journal:  Mol Ther       Date:  2021-03-26       Impact factor: 12.910

6.  Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.

Authors:  Jianwen Jiang; Qiuxian Zheng; Weiwei Zhu; Xinhua Chen; Haifeng Lu; Deying Chen; Hua Zhang; Min Shao; Lin Zhou; Shusen Zheng
Journal:  Aging (Albany NY)       Date:  2020-06-01       Impact factor: 5.682

7.  Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma.

Authors:  Linkun Ma; Cunliang Deng
Journal:  PeerJ       Date:  2019-08-01       Impact factor: 2.984

Review 8.  Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition.

Authors:  Jun-Ting Cheng; Lingzhi Wang; Hong Wang; Feng-Ru Tang; Wen-Qi Cai; Gautam Sethi; Hong-Wu Xin; Zhaowu Ma
Journal:  Cells       Date:  2019-09-30       Impact factor: 6.600

Review 9.  Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer.

Authors:  Alba Loras; Cristina Segovia; José Luis Ruiz-Cerdá
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

Review 10.  Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress.

Authors:  Tie-Ning Zhang; Wei Wang; Ni Yang; Xin-Mei Huang; Chun-Feng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.